Table 1.
Chr | Position in GRCh38 | Ref | Alt | Gene, transcript ID | cDNA, protein | No. of hom or hemi in 1KGP | No. of comp het in 1KGP | 1KGP sample ID(s) | First pathogenic submission: submitter, date, interpretation, evidence | Consensus interpretation as of December 2020 | Submitted interpretations |
---|---|---|---|---|---|---|---|---|---|---|---|
9 | 130,458,549 | G | T | ASS1, NM_054012.4 |
c.323G > T R108L |
1 | 1 |
NA19030 NA19395 |
OMIM, April 2014, Pathogenic NC, heterozygous variant in affected individual | Conflicting Interpretations of Pathogenicity |
1 Pathogenic NC 1 VUS 4 Likely Benign 1 Benign 1 Benign NC |
12 | 109,561,798 | C | T | MMAB, NM_052845.4 |
c.403G > A p.A135T |
1 | 0 | HG03169 | GeneReviews, February 2016, Pathogenic NC, seen in affected individuals | Conflicting Interpretations of Pathogenicity |
1 Pathogenic NC 1 VUS 1 Benign 1 Benign NC |
12 | 120,739,317 | A | G | ACADS, NM_000017.4 |
c.1108A > G p.M370V |
1 | 0 | NA20878 | GeneDx, August 2015, Pathogenic, clinical testing | Conflicting Interpretations of Pathogenicity |
2 VUS 1 Likely Benign |
X | 38,367,361 | G | A | OTC, NM_000531.6 |
c.148G > A p.G50R |
1 | 0 | NA21124 | GenMed Metabolism Lab, April 2014, Pathogenic NC, identified in late-onset individual | Pathogenic, 0 stars | 2 Pathogenic NC |